Anthrax lethal factor proteolysis and inactivation of MAPK kinase

被引:113
|
作者
Chopra, AP [1 ]
Boone, SA [1 ]
Liang, XD [1 ]
Duesbery, NS [1 ]
机构
[1] Van Andel Res Inst, Lab Dev Cell Biol, Grand Rapids, MI 49503 USA
关键词
D O I
10.1074/jbc.M211262200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anthrax lethal toxin produced by the bacterium Bacillus anthracis is the major cause of death in animals infected with anthrax. One component of this toxin, lethal factor (LF), inactivates members of the mitogen-activated protein kinase kinase or MEK family through proteolysis of their NH2 termini. However, neither the substrate requirements for LF cleavage nor the mechanism by which proteolysis inactivates MEK have been demonstrated. By means of deletion mutant analysis and site-directed mutagenesis, we have identified an LFIR ((LF) under bar (i) under bar nteracting region) in the COOH-terminal kinase domain of MEK1 adjacent to the proline-rich region, which is essential for LF-mediated proteolysis of MEK. Point mutations in this region block proteolysis but do not alter the kinase activity of MEK. Similar mutations in MEK6 also prevent proteolysis, indicating that this region is functionally conserved among MEKs. In addition, NH2-terminal proteolysis of MEK1 by LF was found to reduce not only the affinity of MEK1 for its substrate mitogen-activated protein kinase but also its intrinsic kinase activity, indicating that the NH2-terminal end of MEK is important not only for substrate interaction but also for catalytic activity.
引用
收藏
页码:9402 / 9406
页数:5
相关论文
共 50 条
  • [21] Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs
    Bardwell, AJ
    Abdollahi, M
    Bardwell, L
    BIOCHEMICAL JOURNAL, 2004, 378 : 569 - 577
  • [22] Efficient synthetic inhibitors of anthrax lethal factor
    Forino, M
    Johnson, S
    Wong, TY
    Rozanov, DV
    Savinov, AY
    Li, W
    Fattorusso, R
    Becattini, B
    Orry, AJ
    Jung, DW
    Abagyan, RA
    Smith, JW
    Alibek, K
    Liddington, RC
    Strongin, AY
    Pellecchia, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (27) : 9499 - 9504
  • [23] An enzymatic electrochemiluminescence assay for the lethal factor of anthrax
    Rivera, VR
    Merill, GA
    White, JA
    Poli, MA
    ANALYTICAL BIOCHEMISTRY, 2003, 321 (01) : 125 - 130
  • [24] Inhibition of anthrax lethal factor by ssDNA aptamers
    Lahousse, Mieke
    Park, Hae-Chul
    Lee, Sang-Choon
    Ha, Na-Reum
    Jung, In-Pil
    Schlesinger, Sara R.
    Shackelford, Kaylin
    Yoon, Moon-Young
    Kim, Sung-Kun
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, 646 : 16 - 23
  • [25] Anthrax Lethal Factor Investigated by Molecular Simulations
    Hong, Rolando
    Magistrato, Alessandra
    Carloni, Paolo
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2008, 4 (10) : 1745 - 1756
  • [26] The mechanism of action of anthrax toxin lethal factor
    Szeberényi, J
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2002, 30 (01) : 62 - 63
  • [27] Pharmacology - Screening inhibitors of anthrax lethal factor
    Tonello, F
    Seveso, M
    Marin, O
    Mock, M
    Montecucco, C
    NATURE, 2002, 418 (6896) : 386 - 386
  • [28] Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition
    Park, JM
    Greten, FR
    Li, ZW
    Karin, M
    SCIENCE, 2002, 297 (5589) : 2048 - 2051
  • [29] Mechanism of proteolysis of anthrax lethal factor. An ab initio and hybrid QM/MM molecular dynamics study.
    Magistrato, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U763 - U763
  • [30] Inactivation of Rho GTPases by Statins Attenuates Anthrax Lethal Toxin Activity
    deCathelineau, Aimee M.
    Bokoch, Gary M.
    INFECTION AND IMMUNITY, 2009, 77 (01) : 348 - 359